MedTrace Logo

Impact of Multiple Sclerosis From the Viewpoint of the Patients and Their Caregivers

NCT02388334 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1080

Last updated 2026-06-12

No results posted yet for this study

Summary

Patients with chronic illness and their relatives have exhaustive and specific experience of healthcare and the health service.These unique experiences must be taken into account for quality of care management assessment. MS affects young patients whose illness and level of disability will worsen throughout their lives. Half the patients living with MS require a natural (non professional) caregiver's support and this level of investment increases with the degree of disability. No dedicated tools for patients living with MS and their caregivers are currently available to assess their experience of the quality of care management.

Conditions

Interventions

OTHER

to develop standardized questionnaires

The aim of our project is to develop, from the patients living with MS and their natural caregivers' point of view, standardized questionnaires evaluating their experience concerning the global quality of care management, in accordance with psychometric standards. The questionnaires will be developed in two phases : item generation (Phase 1) and validation (Phase 2)

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • Nantes University Hospital

    collaborator OTHER

  • University Hospital, Angers

    collaborator OTHER_GOV

  • Central Hospital, Nancy, France

    collaborator OTHER

  • University Hospital, Strasbourg

    collaborator OTHER

  • University Hospital, Marseille

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    collaborator OTHER

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • David Veillard · Rennes University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-15
Primary Completion
2023-06-13
Completion
2023-06-13

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02388334 on ClinicalTrials.gov